Crossmark

Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial

Published Online: 2022-09-12

Published Print: 2023-01

Authors

Amini Harandi, Ali https://orcid.org/0000-0002-3903-8343
Pakdaman, Hossein

Karamiani, Faezeh

Mohammadi, Faezeh

Shirzadeh Barough, Siavash

Siavoshi, Fatemeh

Ilkhani, Saba

Sahraian, Mohammadali
License Information

Text and Data Mining valid from 2022-09-12

Version of Record valid from 2022-09-12
More Information

Article History

Received: 7 April 2022

Accepted: 1 September 2022

First Online: 12 September 2022

Declarations

:

: None.

: The authors declare no competing interests.

: Ethical approval of the study was obtained from the Research Ethics Committee of Shahid Beheshti University of Medical Sciences. Ethical number:IR.SBMU.REC.1398.049.

Document is current